Dr Wenjian Li

Department of Urology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, China

Dr. Wenjian Li possesses a substantial history of clinical, research, and teaching practice in the domain of urology. He currently serves in the capacity of Chief Physician and Department Head at Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Jiangsu Province, China. His research interests are focused on the study of inflammatory regulatory networks and the mechanisms of immune microenvironmental remodeling in urological diseases and metabolic nephropathy, with a particular emphasis on the pathogenesis of urolithiasis and the progression of diabetic nephropathy.

His research team employs a multifaceted approach, integrating organoid culture, spatial transcriptomics, and metabolic flow analysis technology platforms. The team is dedicated to the construction of predictive models of inflammation-related biomarkers and the development of nano-loaded drug delivery systems targeting immune checkpoints. Dr. Li has served on the editorial boards of several journals and reviewed articles for more than 30 journals.

Updated 14 April 2025